Blacksburg, VA, United States of America

Thomas Piccariello

This inventor holds 41 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Innovations. Top assignees: Shire LLC, Synthonics Incorporated, New River Pharmaceuticals Inc.. Active years: 1995-2023.

USPTO Granted Patents = 41 (Patent Applications = 9)

% Patents Active = 80.5

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 3.7

ph-index = 20

Forward Citations = 1,103(Granted Patents)

Company Filing History:

Synthonics Incorporated

patents

6 out of 9

New River Pharmaceuticals Inc.

patents

4. 2 out of 1,040

University of Virginia Patent Foundation

patents

5. 1 out of 3

Insmed Pharmaceuticals, Inc.

patents

6. 1 out of 834,411

Other

patents

Years Active: 1995-2023

Loading Chart...

Areas of Expertise:

Active Agent Delivery

Abuse-Resistant Compounds

Coordination Complexes

Drug Delivery Systems

Pharmaceutical Solutions

Metal Coordinated Compositions

Dendritic Encapsulation

Sustained Release Compounds

Iodothyronine Compositions

Synthetic Insulin Mimetic

Immunoassay Techniques

Carbohydrate Conjugates

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11712426 - Metallo-liothyronine (2023-08-01),

2. 10150792 - Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients (2018-12-11),

3. 9624256 - Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients (2017-04-18),

4. 8779175 - Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients (2014-07-15),

5. 8716300 - Frequency modulated drug delivery (FMDD) (2014-05-06),

6. 8394813 - Active agent delivery systems and methods for protecting and administering active agents (2013-03-12),

7. 8389726 - Metal coordinated compositions (2013-03-05),

8. 8236787 - Frequency modulated drug delivery (FMDD) (2012-08-07),

9. 8133881 - Carbohydrate conjugates to prevent abuse of controlled substances (2012-03-13),

10. 7989440 - Metal coordinated compositions (2011-08-02),

11. 7799937 - Metal coordinated compositions (2010-09-21),

12. 7723305 - Abuse-resistant amphetamine prodrugs (2010-05-25),

13. 7718619 - Abuse-resistant amphetamine prodrugs (2010-05-18),

14. 7713936 - Abuse-resistant amphetamine prodrugs (2010-05-11),

15. 7700561 - Abuse-resistant amphetamine prodrugs (2010-04-20),

Title: Thomas Piccariello - Pioneering Innovations in Pharmaceuticals

Introduction:

Thomas Piccariello, a distinguished inventor based in Blacksburg, VA (US), has made significant contributions to the field of pharmaceuticals with his groundbreaking innovations. With an impressive portfolio of 41 patents, his work focuses on developing novel treatments for a range of medical conditions.

Latest Patents:

One of Piccariello's latest inventions is the Metallo-liothyronine, a supramolecular metal coordinated liothyronine composition that offers new methods for treating hypothyroidism and other diseases. Additionally, his work on bismuth-containing compounds and coordination polymers showcases innovative approaches to modulating pharmacokinetic properties of biologically active agents.

Career Highlights:

Having worked with esteemed companies such as Shire LLC and Synthonics Incorporated, Piccariello has honed his skills and expertise in the pharmaceutical industry. His dedication to research and development has led to transformative solutions that improve patient outcomes and advance medical science.

Collaborations:

Throughout his career, Piccariello has collaborated with industry experts such as Travis C Mickle and James Scott Moncrief. These partnerships have been instrumental in driving forward his research projects and bringing innovative ideas to fruition.

Conclusion:

Thomas Piccariello's passion for innovation and his relentless pursuit of scientific excellence have established him as a leading figure in the field of pharmaceutical inventions. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the realm of healthcare innovations.